Bayer Pre-Tax Income 2010-2024 | BAYRY

Bayer pre-tax income for the twelve months ending December 31, 2024 was $-2.526B, a 43.96% increase year-over-year.

  • Bayer annual pre-tax income for 2024 was $-2.526B, a 43.96% increase from 2023.
  • Bayer annual pre-tax income for 2023 was $-1.754B, a 135.66% decline from 2022.
  • Bayer annual pre-tax income for 2022 was $4.92B, a 103.27% increase from 2021.

Bayer Pre-Tax Income 2010-2024 | BAYRY

  • Bayer annual pre-tax income for 2024 was $-2.526B, a 43.96% increase from 2023.
  • Bayer annual pre-tax income for 2023 was $-1.754B, a 135.66% decline from 2022.
  • Bayer annual pre-tax income for 2022 was $4.92B, a 103.27% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$796.4B
Johnson & Johnson (JNJ)$379.5B
AbbVie (ABBV)$306B
Novo Nordisk (NVO)$260.6B
Roche Holding AG (RHHBY)$248.1B
Novartis AG (NVS)$234.2B
Merck (MRK)$196.7B
Sanofi (SNY)$128.6B
Pfizer (PFE)$125.6B
Innoviva (INVA)$1.1B